United States · FDA National Drug Code directory
ziprasidone hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60505-2529_c536546b-c1a2-8363-a294-3655ef542fd8
- Product NDC
- 60505-2529
- Form
- CAPSULE
- Composition / generic term
- Ziprasidone HCl
- Labeler
- Apotex Corp.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20120514
- Source listing expiry
- 20271231
Source-listed ingredients
- ZIPRASIDONE HYDROCHLORIDE — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 CAPSULE in 1 BOTTLE (60505-2529-6) · 60505-2529-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →